Varenne Capital Partners Sarepta Therapeutics, Inc. Transaction History

Varenne Capital Partners

  • $514 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 27, 2022
SELL
$62.69 - $88.44 $18.5 Million - $26.2 Million
-295,733 Closed
0 $0
Q1 2022

May 12, 2022
SELL
$63.15 - $90.42 $1.83 Million - $2.62 Million
-28,928 Reduced 8.91%
295,733 $23.1 Million
Q4 2021

Feb 14, 2022
BUY
$77.28 - $99.42 $25.1 Million - $32.3 Million
324,661 New
324,661 $29.2 Million

Others Institutions Holding SRPT

# of Institutions
529
Shares Held
84.2M
Call Options Held
2.06M
Put Options Held
1.52M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Varenne Capital Partners Portfolio

Follow Varenne Capital Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Varenne Capital Partners, based on Form 13F filings with the SEC.

News

Stay updated on Varenne Capital Partners with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email